US Stock MarketDetailed Quotes

VTRS Viatris

Watchlist
  • 11.480
  • +0.090+0.79%
Close Feb 25 16:00 ET
  • 11.450
  • -0.030-0.26%
Pre 05:05 ET
13.70BMarket Cap-15.73P/E (TTM)

About Viatris Company

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Company Profile

SymbolVTRS
Company NameViatris
Listing DateFeb 1, 1973
Founded2019
CEOMr. Scott A. Smith
MarketNASDAQ
Employees38000
Fiscal Year Ends12-31
AddressRobert J. Coury Global Center,1000 Mylan Boulevard
CityCanonsburg
ProvincePennsylvania
CountryUnited States of America
Zip Code15317
Phone1-724-514-1800

Company Executives

  • Name
  • Position
  • Salary
  • Scott A. Smith
  • Director and Chief Executive Officer
  • 15.93M
  • Theodora Mistras
  • Chief Financial Officer
  • --
  • Dr. Corinne Le Goff, Pharm.D.
  • Chief Commercial Officer
  • --
  • Paul B. Campbell
  • Chief Accounting Officer and and Corporate Controller
  • --
  • Brian Roman
  • Chief Legal Officer
  • 4.11M
  • Mark W. Parrish
  • Vice Chairman of the Board
  • 450.01K
  • Melina E. Higgins
  • Chairman of the Board
  • 454.38K
  • Robert J. Coury
  • Chairman Emeritus
  • 41.50M
  • Rajiv Malik
  • Director
  • 12.48M
  • Richard A. Mark, C.P.A.
  • Independent Director
  • 420.01K
  • JoEllen Lyons Dillon
  • Independent Director
  • 400.01K
  • James M. Kilts
  • Independent Director
  • 370.01K
  • Elisha W. Finney
  • Independent Director
  • 370.01K
  • Wyllie Don Cornwell
  • Independent Director
  • 370.01K
  • Leo Groothuis
  • Independent Director
  • 313.54K
  • Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
  • Independent Director
  • --
  • Harry A. Korman
  • Independent Director
  • 375.01K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More